We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » First Generic Moving Through EMEA Centralized Procedure
First Generic Moving Through EMEA Centralized Procedure
August 15, 2007
The European Medicines Agency (EMEA) has, for the first time, adopted a positive opinion recommending approval of a generic version of a drug approved under the agency’s centralized procedure, the agency announced last month.